Hostname: page-component-7c8c6479df-r7xzm Total loading time: 0 Render date: 2024-03-29T02:07:22.984Z Has data issue: false hasContentIssue false

Food-derived serotonergic modulators: effects on mood and cognition

Published online by Cambridge University Press:  18 October 2013

Sjoerd Hulsken
Affiliation:
Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Geert Grooteplein 21 (route 126), 6525 EZNijmegen, The Netherlands
Antje Märtin
Affiliation:
Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Geert Grooteplein 21 (route 126), 6525 EZNijmegen, The Netherlands
M. Hasan Mohajeri
Affiliation:
DSM Nutritional Products Ltd, R&D Human Nutrition and Health, Basel, Switzerland
Judith Regina Homberg*
Affiliation:
Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Geert Grooteplein 21 (route 126), 6525 EZNijmegen, The Netherlands
*
*Corresponding author: Dr J. R. Homberg, fax +31 24 354 14 35, email j.homberg@cns.umcn.nl
Rights & Permissions [Opens in a new window]

Abstract

The most frequently described drugs in the treatment of mood disorders are selective serotonin reuptake and monoamine oxidase (MAO) inhibitors, enhancing serotonin levels in the brain. However, side-effects have been reported for these drugs. Because serotonin levels in the brain are dependent on the availability of the food-derived precursor tryptophan, foods such as chicken, soyabeans, cereals, tuna, nuts and bananas may serve as an alternative to improve mood and cognition. Here we discuss the effects of high- or low-tryptophan-containing food, as well as plant extracts with a modest monoamine reuptake and MAO-A inhibition functional profile, on mood and cognition in healthy and vulnerable human subjects and rodents. Together the studies suggest that there is an inverted U-shaped curve for plasma tryptophan levels, with low and too high tryptophan levels impairing cognition, and moderate to high tryptophan levels improving cognition. This relationship is found for both healthy and vulnerable subjects. Whereas this relationship may also exist for mood, the inverted U-shaped curve for plasma tryptophan levels and mood may be based on different tryptophan concentrations in healthy v. vulnerable individuals. Animal studies are emerging and allow further understanding of effects and the mode of action of food-derived serotonergic components on mood, cognition and mechanisms. Ultimately, insight into the concentrations of tryptophan and other serotonergic components in food having beneficial effects on mood and cognition in healthy, but particularly vulnerable, subjects may support well-being in our highly demanding society.

Type
Research Article
Copyright
Copyright © The Authors 2013 

Introduction

Food is a primary requirement to live. Yet, even when food is abundantly available, food could also be used as a powerful tool to increase mental well-being. Stress-related mental disorders such as mood or anxiety disorders are the most prevalent (10 to 25 % women and 5 to 12 % men are being diagnosed each year(1)), and burdensome, psychiatric disorders. They are characterised by low mood states and cognitive impairments such as reduced learning and memory(1). Thus, the exploitation of resilience or mood/cognition-enhancing food is of extreme value. Yet, whereas pharmacological manipulations have been abundantly applied, surprisingly little is known about the effects of food on mood and cognition.

The monoamine systems are strongly tied to stress resilience and the (patho)physiology of mood and mood disorders. As such, tricyclic antidepressants (inhibiting serotonin and noradrenaline reuptake) and selective serotonin reuptake inhibitors (SSRI) are frequently prescribed drugs in the treatment of these disorders. To a limited extend these agents also inhibit dopamine reuptake. Whereas antidepressant drugs are considered as healthy drugs, their uncontrolled intake is not without risks. For instance, at a young age these drugs may affect brain development and increase suicide(Reference Olivier, Chan and Snoeren2). Furthermore, triple monoamine reuptake inhibition corresponds to the function of cocaine, which is a powerful psychostimulant with abuse potential. In addition to monoamine reuptake inhibitors, also drugs that inhibit the breakdown of monoamines are used to improve mood, particularly monoamine oxidase A (MAO-A) inhibitors. However, these agents are also associated with substantial side effects. A major risk is the serotonin syndrome; too high levels of serotonin are toxic. Hence, whereas monoamine reuptake inhibitors and MAO-A inhibitors improve mood, particularly in individuals with a low mood state, their use is not without risks.

To improve mood by other means, food with high tryptophan (Trp) availability and modest monoamine reuptake and MAO-A inhibition functional profile may be effective. The serotonin precursor Trp is an essential amino acid that in mammals can only be derived from food(Reference Wurtman, Hefti and Melamed3). Therefore, Trp levels in food appear to be an essential link in the relationship between food intake and our mood state. Accordingly, high-Trp-containing foods (for example, chicken, soyabeans, cereals, tuna, nuts and bananas) are presented on the Internet as food to improve mood. Furthermore, sometimes unknowingly, the Trp content of food has been increased. For instance, Neolithic Mesopotamia-cultivated chickpeas contained more Trp than wild varieties(Reference Kerem, Lev-Yadun and Gopher4). Another example is the treatment of maize with alkali by various cultures in America, which enhances the bioavailability of Trp(Reference Katz, Hediger and Valleroy5, Reference Morris and Sands6). More recently, research into α-lactalbumin has revealed that this whey-derived protein has the highest Trp content of all proteins found in food and therefore is added to infant milk formulas(Reference Heine, Radke and Wutzke7). Finally, an even more promising source of Trp is egg protein hydrolysate(Reference Mitchell, Slettenaar and Quadt8). Pharmacological studies have confirmed that products that increase Trp levels increase serotonin levels in the brain, and apparently modulate processing in the neurocircuits regulating mood to enhance mood(Reference Markus, Firk and Gerhardt9, Reference Silber and Schmitt10). Trp depletion, on the other hand, is well known to affect mood negatively(Reference Booij, Van der Does and Riedel11). Hence, controlling the amount of Trp in food has substantial effects on mood regulation and well-being, although data as discussed in the present review indicate that the relationship between Trp levels and mood is less straightforward than we tend to think. Foods having triple monoamine reuptake and MAO-A inhibitor function have been less extensively investigated, even though they may offer another natural source to boost mood. Indeed, these foods have significant anti-depressive and anxiolytic effects in rats which are comparable with the effects of antidepressant reference drugs(Reference Mechan, Fowler and Seifert12).

The aim of the present review is to provide an update about foods influencing the serotonergic system that have potential to increase stress resilience and thereby our well-being. Rather than applying pharmacological drugs when pathology has developed, prevention by healthy foods may decrease the burden associated with mood disorders. An important consideration is the heterogeneity of mood disorders, caused by genetic or other biological factors. Along with the fact that there are large individual differences in vulnerability to mood disorders, there are large individual differences in responsivity to antidepressant agents(Reference Kroeze, Zhou and Homberg13), as well as in responsivity to serotonergic food components. These individual differences play a leading role in our discussion of the effects of serotonergic foods on mood. In sum, the present review discusses the serotonergic system, and the influence of serotonergic food components on mood and cognition in healthy, genetically vulnerable and clinically depressed and recovered populations, as well as (genetic) rodent models.

The serotonergic system

Serotonin, or 5-hydroxytryptamine (5-HT), is an ancient monoamine, as even some unicellular organisms are able to synthesise it. Furthermore, it is found in basically all animal species and various plants such as stinging nettles and walnuts. Apart from its roles in the cardiovascular and digestive systems, 5-HT is an important neurotransmitter with a wide variety of actions in different brain regions. Because 5-HT as a hydrophilic molecule is unable to cross the blood–brain barrier, it is synthesised in the brain, specifically the serotonergic neurons in the raphe nuclei itself, by the enzyme tryptophan hydroxylase 2 (TpH2). TpH2 is also expressed in myenteric neurons in the gut(Reference Neal, Parry and Bornstein14). TpH2 is distinct from tryptophan hydroxylase 1 (Tph1), the enzyme that is responsible for the 5-HT system in the peripheral system, mainly the gut. The synthesis of 5-HT in the brain takes place in the axon terminals of serotonergic neurons where TpH2 exerts the first rate-limiting step. TpH2 hydroxylates l-tryptophan and forms 5-hydroxytryptophan. This molecule is subsequently decarboxylated by aromatic l-amino acid decarboxylase to form 5-HT. The 5-HT molecules are stored in vesicles in the serotonergic neurons. Upon an action potential, 5-HT is released from axon terminals of serotonergic neurons into the synaptic cleft where it binds to its receptors on the postsynaptic neuron. Its activity is terminated by the serotonin transporter (5-HTT) in the membrane of the presynaptic neuron that transports 5-HT back into the cell. This allows recycling of 5-HT, although stored/released 5-HT is also degraded by MAO-A. Fine-tuning of the postsynaptic response to the release of 5-HT is achieved through a host of different receptors and cells and/or brain area-specific receptor profiles, thereby facilitating the different roles that 5-HT plays in physiological and behavioural functions.

Serotonergic cell bodies are located in the raphe nuclei, a cluster of nuclei in the brain stem projecting to almost all brain regions(Reference Azmitia, Whitaker-Azmitia, Bloom and Kupfer15), including lateral cortical regions, the amygdala and the hypothalamus, which are all involved in processing emotions and stress. Because TpH2, 5-HTT and MAO-A are expressed in these and other brain areas(Reference Gutknecht, Kriegebaum and Waider16Reference Torres, Gainetdinov and Caron18), agents acting through TpH2, 5-HTT and MAO-A will have a global effect on 5-HT neurotransmission.

Although the precise role of 5-HT in mood disorders such as depression, obsessive-compulsive disorder and anxiety is not fully understood, it is evident that the 5-HT system is perturbed in these disorders. The synthesis, release, reuptake and/or metabolism of 5-HT(Reference Van Praag, Korf and Puite19, Reference Malison, Price and Berman20), as well as the functionality of the 5-HT1A and 5-HT2 serotonin receptors(Reference Cowen, Power and Ware21, Reference Sargent, Kjaer and Bench22), are to different extents affected in anxiety and depression. The general view is that there is an inverse relationship between depression and 5-HT levels, based on the antidepressive properties of serotonin-enhancing drugs(Reference Nutt23). In terms of food, a positive association between the consumption of maize, which contains less Trp compared with other food staples, and homicide rates has been found(Reference Mawson and Jacobs24). Moreover, another cross-national study revealed a negative correlation between dietary Trp and suicide rates(Reference Voracek and Tran25).

There is also evidence that genetic variation in the serotonergic system increases vulnerability to anxiety- and depression-related disorders(Reference Gordon and Hen26Reference Maes, Meltzer, Bloom and Kupfer29). A common polymorphism in the promoter region of the 5-HTT (SLC6A4) gene (abbreviated: 5-HTTLPR; serotonin-transporter-linked polymorphic region) is associated with trait anxiety(Reference Lesch, Bengel and Heils30), and in the context of (early-life) stress, this polymorphism increases risk for depression(Reference Caspi, Sugden and Moffitt31). Paradoxically, it is the low-activity short (s) allelic variant that increases vulnerability. Although human studies could not provide evidence, studies employing 5-HTT knockout mice and rats have revealed that reduced 5-HTT expression is associated with increased synaptic 5-HT levels(Reference Kalueff, Olivier and Nonkes32). Hence, whereas SSRI-induced increases in 5-HT levels reduce depressive symptoms, genetically induced constitutive high 5-HT levels appear to increase these symptoms. Furthermore, whereas 5-HTTLPR s-allele carriers are at risk for depression if exposed to stress, those that are depressed suffer from decreased responsivity to SSRI. Intuitively, decreased 5-HTT expression leaves a smaller window of opportunity for SSRI to exert their maximum effects.

In 1998, gene mapping of the X-chromosomal MAO-A gene revealed a functional polymorphism in the upstream promoter region, consisting of a variable number of tandem repeats (u-VNTR). The different lengths of these variants was found to influence protein transcription and thus enzymic activity(Reference Sabol, Hu and Hamer33). Others linked the alleles which confer high enzymic activity (three, four and five repeats) to several anxiety- and depression-related disorders(Reference Deckert, Catalano and Syagailo34Reference Yu, Tsai and Hong37), as well as reduced responsiveness to antidepressant treatment(Reference Yu, Tsai and Hong37, Reference Domschke, Braun and Ohrmann38).

Finally a number of different TpH2 SNP have been reported in several ethnical cohorts which are thought to cause, through either lower enzymic activity or loss of function, lower extracellular 5-HT levels. Zhang et al. (Reference Zhang, Gainetdinov and Beaulieu39) showed that an 80 % loss of function TpH2 G1463A SNP found in a geriatric sample in North Carolina (USA) was more prevalent in the cohort diagnosed with unipolar depression compared with the matching control cohort. Another study revealed in Taiwanese Han Chinese subjects a possible association between bipolar disorder and TpH2 C2755A, which leads to a reduction of 5-HT synthesis when expressed in cells(Reference Lin, Chao and Chen40), and TpH2 Pro206Ser (conferring a 30 % reduction in enzymic activity) was found to be significantly higher expressed in a cohort of German patients suffering from bipolar disorder compared with controls(Reference Cichon, Winge and Mattheisen41). In addition to these SNP, the study on Taiwanese Han Chinese also reported that the − 703G/ − 473A haplotype (a TpH2 promoter variant associated with bipolar disorder) resulted in reduced transcription of the TpH2 gene as well as reduced affinity for the transcription factor POU3F2(Reference Lin, Chao and Chen40).

Because 5-HTT, Thp2 and/or MAO-A polymorphisms affect the functioning of the serotonergic system, it is to be expected that they influence the effects of serotonergic food components, either through reduced capacity to convert Trp into 5-HT (due to reduced TpH2 function), reduced sensitivity of the serotonergic system to elevated 5-HT levels (due to reduced 5-HTT function) or enhanced degradation of 5-HT (due to elevated MAO-A activity).

Tryptophan

Since 5-HT cannot cross the blood–brain barrier due to its hydrophilic properties the synthesis of the neurotransmitter takes place in the axon terminals of serotonergic neurons. The precursor Trp is absorbed from food into the bloodstream. When a meal containing protein is consumed a large proportion of Trp entering the portal vein is metabolised in the liver, which does not happen with the other large neutral amino acids (LNAA)(Reference Ross, Fernstrom and Wurtman42). Thus the amount of Trp entering the circulation is much less compared with other LNAA, if the amounts consumed are the same. However, the secretion of insulin in response to the intake of carbohydrates in the meal reduces the plasma concentrations of all LNAA except Trp, which binds to albumin and thereby can circulate throughout the body(Reference Yuwiler, Oldendorf and Geller43, Reference Fernstrom, Larin and Wurtman44). Whether a meal increases the ratio of plasma Trp levels compared with the plasma levels of other LNAA (the TRP:LNAA ratio) depends on the amount of protein digested and the release of insulin(Reference Fernstrom and Wurtman45, Reference Fernstrom and Faller46). When Trp in the circulation reaches the brain capillaries it is transported across the blood–brain barrier. Here Trp has to compete with other LNAA for active transport across the cell membranes of the epithelial cells lining the capillaries. Therefore, not the plasma level of Trp alone, but the TRP:LNAA ratio determines its rate of transport across the blood–brain barrier(Reference Fernstrom and Wurtman45). Once inside the brain, Trp is taken up by the serotonergic cells of the raphe nuclei and via two enzymic reactions it is converted into 5-HT (see the section on the serotonergic system).

Acute tryptophan depletion

Since there is a direct relationship between dietary Trp and brain 5-HT synthesis, the supply of 5-HT in the brain can be exhausted by decreasing the availability of Trp. A standardised procedure to drastically decrease the levels of 5-HT is acute tryptophan depletion (ATD). In short, a diet low in Trp is eaten by the subjects for 24 h, after which they fast overnight and during the test day except for a shake which contains all amino acids excluding Trp. This in itself causes a drop in the plasma TRP:LNAA ratio. Furthermore, protein synthesis is stimulated by the intake of high-protein foods or drinks. A protein-rich low-carbohydrate diet results in a decreased amount of Trp in the brain since the TRP:LNAA ratio in normal protein is very low. Therefore, a protein-rich low-carbohydrate diet results in more competition for the transport system over the blood–brain barrier and consequently less transport of Trp into the brain. As a consequence, Trp needed for protein synthesis during the diet and test day must be supplied by the reserves in the body. Inevitably these reserves will be drained to the point that they cannot maintain plasma Trp levels, causing the TRP:LNAA ratio to drop even further, to about 15 % within 5·5 h. Brain Trp levels drop to 5 % several hours later, which hampers brain 5-HT synthesis(Reference Carpenter, Anderson and Pelton47Reference Williams, Shoaf and Hommer49). The effects of ATD in healthy volunteers and vulnerable subjects are described in the following sections.

Effects of acute tryptophan depletion on mood and cognitive functions in healthy subjects

Mood

In line with the increased incidence of depression in women, it has been reported that the mood of healthy female volunteers but not of healthy male volunteers dropped after ATD (about 80–90 % reduction in plasma Trp)(Reference Ellenbogen, Young and Dean50, Reference Smith, Clifford and Hockney51). In male subjects, effects of ATD on mood were either small(Reference Smith, Pihl and Young52, Reference Young, Smith and Pihl53) or fully absent (about 70–90 % reduction in plasma Trp)(Reference Ellenbogen, Young and Dean50, Reference Smith, Clifford and Hockney51, Reference Abbott, Etienne and Franklin54, Reference Danjou, Hamon and Lacomblez55). positron emission tomography (PET) imaging showed that there may be differences in 5-HT synthesis and metabolism between the sexes, which could explain the difference in response to ATD(Reference Nishizawa, Benkelfat and Young48). Other studies reported that the performance of men in the Stroop Color Word Test, testing selective attention and response inhibition, improved following ATD (about 60–80 % reduction in plasma Trp)(Reference Schmitt, Jorissen and Sobczak56, Reference Scholes, Harrison and O'Neill57). However, the effects of ATD on recognition of emotional faces are inconsistent; some observed a decrease in recognition of facial emotions following ATD (no complete data on plasma Trp) in women(Reference Harmer, Rogers and Tunbridge58), others found an increase in the recognition of happy faces by women (plasma Trp reduced by 55 %)(Reference Hayward, Goodwin and Cowen59), and still others reported no effects in both men and women following a Trp reduction of 65 %(Reference Van Der Veen, Evers and Deutz60, Reference Cools, Calder and Lawrence61). Thus, whereas ATD impairs mood in women, there are conflicting results concerning the effects of ATD on the recognition of emotional faces.

Cognition

Apart from mood, ATD has been found to affect a number of cognitive functions in healthy individuals. Memory consolidation was impaired when the learning of a list of words took place during the Trp-depleted state (about 60–80 % reduction in plasma Trp), whereas the recall of word lists learned before the ATD procedure was not affected(Reference Schmitt, Jorissen and Sobczak56, Reference Riedel, Klaassen and Deutz62). Moreover, McAllister et al. (Reference McAllister-Williams, Massey and Rugg63) showed that ATD leading to a plasma Trp reduction of 85 % significantly impaired source memory recall. In sum, research consistently shows memory impairment following ATD.

Effects of acute tryptophan depletion on mood and cognitive functions in vulnerable subjects

Mood

In vulnerable and subclinical subjects more consistent evidence has been found pointing towards a lowering of mood and alterations in cognitive functioning in response to ATD. For instance, healthy subjects with a multigenerational family history of affective disorders showed a reduction in mood as measured the by the Profile of Mood States scale following ATD (about 70–90 % reduction in plasma Trp)(Reference Benkelfat, Ellenbogen and Dean64, Reference Klaassen, Riedel and van Someren65). The same is true for patients who are remitted from a depressive episode and responded to SSRI treatment (Trp plasma reduced by about 50–90 %)(Reference Delgado, Charney and Price66Reference Smith, Fairburn and Cowen69); however, see Leyton et al. (Reference Leyton, Young and Blier70). In remitted depressed patients, ATD impaired attention to positive stimuli (about 55–64 % reduction in plasma Trp)(Reference Booij, Van der Does and Haffmans71) and decreased the recognition of fearful and happy faces (plasma Trp reduced by 55–84 %)(Reference Hayward, Goodwin and Cowen59, Reference Merens, Booij and Haffmans72). Furthermore, in otherwise healthy women as well as remitted major depression patients carrying the 5-HTTLPR ss or ls genotype it was found that ATD significantly lowered mood compared with l-allele carriers (about 70–85 % reduction in plasma Trp)(Reference Neumeister, Konstantinidis and Stastny73Reference Walderhaug, Magnusson and Neumeister75). Interestingly, men carrying the same genotype did not experience a lower mood, but instead showed increased impulsivity after ATD (plasma Trp reduced by about 75–85 %)(Reference Walderhaug, Magnusson and Neumeister75, Reference Walderhaug, Herman and Magnusson76). When ATD (77 % reduction in plasma Trp) was combined with a stressor, mood deteriorated even further in 5-HTTLPR ss subjects, while no further reduction was found in individuals homozygous for the l allele(Reference Firk and Markus77). In summary, a vulnerable serotonergic system, whether due to genetic background or a (family) history of affective disorders, seems to enhance the mood-deteriorating effects of ATD.

Cognition

Subclinical subjects tend to suffer from instable cognitive function, which increases the risk of cognitive impairments when cognitive capacities are too low to properly deal with environmental challenges, like stress, but also unhealthy food. In their pooled analysis of nine separate ATD trials, Sambeth et al. (Reference Sambeth, Blokland and Harmer78) discovered that the memory impairment effect of ATD (63–97 % reduction in plasma Trp) was more prominent in women than in men(Reference Sambeth, Blokland and Harmer78). ATD (plasma Trp reduced by 69 %) also lowered incentive motivation in 5-HTTLPR s-allele carriers(Reference Roiser, Blackwell and Cools79). In remitted depressed patients, ATD impaired immediate verbal recall as well as immediate and delayed recall of lists of spoken words (plasma Trp reduced by 55–71 %)(Reference Hayward, Goodwin and Cowen59, Reference Porter, Phipps and Gallagher80, Reference Roiser, Muller and Clark81). However, it improved attention to neutral stimuli (about 55–64 % reduction in plasma Trp)(Reference Booij, Van der Does and Haffmans71).

Effects of acute and (sub-)chronic tryptophan depletion in animal models

While the behavioural effects of ATD on human subjects are well documented, research on the effects of Trp depletion in animal models can offer further insight into the role of 5-HT in mood and cognitive processes and enable researchers to examine the effects of (sub-)chronic Trp depletion. For instance, sub-chronic Trp depletion (SCTD) (57 % reduction in plasma Trp, prefrontal cortex 5-HT levels reduced by 34 %) in Sprague–Dawley rats led to depression-related behaviour in the forced swim test as well as an increase in corticosterone, aldosterone, 5-HT receptor density and increased N-methyl-D-aspartate (NMDA) signalling(Reference Franklin, Bermudez and Murck82). In another study reward learning was impaired without an effect on motivation, assessed by effort discounting and reversal learning tasks, following SCTD (no data on plasma Trp levels, ventromedial frontal cortex 5-HT levels reduced to about 50 % of control) in Long Evans rats(Reference Izquierdo, Carlos and Ostrander83). SCTD (no data on plasma Trp levels, prefrontal cortex 5-HT levels reduced to 39 % of control) in Wistar rats also resulted in enhanced proneness to gamble and poor decision making in the rodent Iowa Gambling Task(Reference Koot, Zoratto and Cassano84). Interestingly, also in macaques performing a gambling task, ATD (about 65 % reduction in plasma Trp) increased risky decision making(Reference Long, Kuhn and Platt85). Chronic Trp depletion in Lister hooded rats (40–50 % reduction of 5-HT levels in the hippocampus, frontal cortex and striatum) impaired object recognition in the novel object-recognition paradigm, which was reversed by administering the atypical antipsychotic risperidone(Reference Jenkins, Elliott and Ardis86). ATD studies in rats have also revealed that the effects of ATD (about 50 % reduction in plasma Trp) on hippocampal and frontal cortex 5-HT levels were more pronounced in homozygous serotonin transporter knockout Wistar rats compared with heterozygous knockout rats and wild-type controls(Reference Olivier, Jans and Korte-Bouws87). Finally, the circadian rhythm of locomotor activity as well as the sleep–wake cycle were found to be disturbed in Sprague–Dawley rats by ATD (99 % reduction in plasma Trp, 85 % decrease in 5-HT brain levels)(Reference Nakamaru-Ogiso, Miyamoto and Hamada88). In conclusion, animal studies have provided evidence that Trp depletion indeed lowers 5-HT levels in brain areas that are involved in several cognitive functions and mood, thus reinforcing the conclusions drawn from human ATD studies and providing further insight into the underlying processes. However, some care should be taken when reviewing these studies on Trp depletion in rats, as not all strains respond in the same manner to Trp depletion(Reference Jans, Korte-Bouws and Korte89).

Summary of acute tryptophan depletion

In healthy subjects the negative effects of ATD on memory are the most profound, while it seems to enhance selective attention and inhibition of response. Interestingly, the lowering of mood by ATD in healthy subjects is only consistently found in females. This sex effect may be a consequence of lower 5-HT synthesis in females than in males(Reference Nishizawa, Benkelfat and Young48), making females more vulnerable to manipulation of the serotonergic system. This is also true for subjects that have a vulnerable serotonergic system as a result of genetic or (family) history of affective disorder, as is seen in the enhanced lowering of mood and negative effects on several cognitive functions in these vulnerable subpopulations.

Acute tryptophan supplementation

Whereas consumption of a high-protein low-carbohydrate diet lowers Trp levels(Reference Fernstrom90), consumption of a diet high in carbohydrates increases the Trp:LNNA ratio in blood and the brain(Reference Fernstrom, Larin and Wurtman44, Reference Fernstrom and Wurtman91). The intake of a high amount of carbohydrates triggers the release of insulin that in turn stimulates the uptake of LNAA into muscle tissue, with the exception of Trp, which is loosely bound by free albumin. Combined with a low intake of protein, the plasma TRP:LNAA ratio shifts in favour of Trp and therefore increases the transport of Trp over the blood–brain barrier. This method, however, only mildly elevates Trp levels in the brain, rarely exceeding an elevation of 25 % over baseline. Furthermore, most typical diets high in carbohydrates are high in protein as well, negating their effect on plasma Trp levels(Reference Yokogoshi and Wurtman92). A valid alternative is the administration of pure Trp via intravenous injection in which the precise elevation of pure Trp levels can be observed. This method, however, proves to be quite invasive and inconvenient as a regular event. Yet another approach is oral administration of a drink high in α-lactalbumin retrieved from whey which is high in Trp(Reference Heine, Radke and Wutzke7) and therefore can increase plasma Trp without increasing the amount of competing LNAA. In several studies, α-lactalbumin was administered as a chocolate-flavoured drink; thus this method is much more feasible for a continued administration and even rather pleasant for the test subject, although the increase in Trp via this method is limited and significantly lower than via intravenous injection(Reference Markus, Olivier and Panhuysen93, Reference Orosco, Rouch and Beslot94). More recently hydrolysed protein and egg protein hydrolysate in the form of a sweetened drink have been found to raise brain Trp up to 255 %, so oral administration does not necessarily produce a smaller increase in plasma Trp than pure intravenous injections(Reference Mitchell, Slettenaar and Quadt8, Reference Markus, Firk and Gerhardt9). Independent of the method, an increased amount of Trp in the brain results directly in an increase in 5-HT synthesis since the rate-limiting enzyme TpH2 is only half saturated under normal circumstances and 5-HTP aromatic l-amino acid decarboxylase is a highly active enzyme(Reference Markus, Firk and Gerhardt9).

In the last decades, there have been many studies on the effects of acute Trp supplementation (ATS) on mood and cognition, utilising either amino acid drinks containing pure Trp, α-lactalbumin, hydrolysed protein or egg protein hydrolysate. Because there is no standardised protocol for ATS, the obtained Trp:LNAA levels after digestion of the ATS mixture or diet can differ greatly between studies. Nonetheless, significant effects of ATS have been observed in both healthy and (sub)clinical populations. In the next sections modulation of various cognitive functions and mood by ATS in healthy and vulnerable subjects will be discussed.

Effects of acute tryptophan supplementation on mood and cognitive functions in healthy subjects

Mood

ATS seems to modulate emotional processing in healthy subjects, in a dose-dependent manner. An oral dose of 1·8 g Trp (600 % increase in TRP:LNAA) increased the recognition of fearful and happy faces in females(Reference Attenburrow, Williams and Odontiadis95). Murphy et al. (Reference Murphy, Longhitano and Ayres96) found increased recognition of happy facial expressions, and a decreased recognition of expressions of disgust after 14 d of 3 g Trp/d (no data on TRP:LNAA ratio) in healthy female subjects. In another study, drinks containing a hydrolysed egg-white protein, which increases plasma TRP:LNAA by 191–255 %, improved mood(Reference Markus, Firk and Gerhardt9). However, carbohydrate-rich protein-poor diets or drinks containing α-lactalbumin that increase plasma TRP:LNAA by 21–67 % did not have an effect on mood(Reference Markus, Firk and Gerhardt9, Reference Markus, Olivier and Panhuysen93, Reference Markus, Panhuysen and Tuiten97Reference Booij, Merens and Markus100). Furthermore, unphysiologically high increases in TRP:LNAA ratios negatively affected mood, as was reported after an intravenous injection of 7 g pure Trp (1500 % increase in TRP:LNAA)(Reference Sobczak, Honig and Van Duinen101, Reference Sobczak, Honig and Schmitt102). Thus, there may be an inverted U-shaped relationship between TRP:LNAA ratios and mood in healthy subjects.

Cognition

Considering that memory consolidation and recall are impaired after ATD and in depression(Reference Schmitt, Jorissen and Sobczak56, Reference Riedel, Klaassen and Deutz62, Reference McAllister-Williams, Massey and Rugg63), ATS may enhance these cognitive functions. Indeed, it has been reported that an increase of 21 % in TRP:LNAA following the administration of two α-lactalbumin-rich drinks improved abstract visual memory in healthy subjects(Reference Booij, Merens and Markus100). However, Sobczak et al. (Reference Sobczak, Honig and Schmitt102) found that an intravenous injection of 7 g Trp had an adverse effect on performance in memory tests. Given that extreme elevation of TRP:LNAA (1500 %) caused significant sedation in the test subjects(Reference Sobczak, Honig and Schmitt102, Reference Luciana, Burgund and Berman103), these detrimental effects could well be due to sedation and not a direct effect of increased 5-HT levels. For instance, ATS (770 % increase in plasma free Trp, no data on TRP:LNAA ratio) has been found to increase reaction times(Reference Murphy, Longhitano and Ayres96, Reference Morgan, Parry and Arida104) and subjective fatigue(Reference Cunliffe, Obeid and Powell-Tuck105) in both healthy subpopulations. Thus, ATS-induced TRP:LNAA increases of 21–43 % have beneficial effects on memory functions, whereas higher increases impair memory, potentially due to sedative effects.

Effects of acute tryptophan supplementation on mood and cognitive functions in vulnerable subjects

Mood

In contrast to ATS effects on mood in healthy subjects, an increase in the plasma TRP:LNAA ratio of 41–48 % following ATS was sufficient to improve mood as well as vigor in high-stress-vulnerable subjects undergoing laboratory stress(Reference Markus, Olivier and Panhuysen93, Reference Markus, Panhuysen and Tuiten97). Other studies found that in women with premenstrual complaints, ATS (29 % increase in Trp:LNAA) improved mood during the premenstrual stage(Reference Sayegh, Schiff and Wurtman106, Reference Schmitt, Jorissen and Dye107). Furthermore, in 5-HTTLPR s-allele, but not l-allele, carriers, ATS (increase in plasma TRP:LNAA of 190 %) was found to have positive effects on mood and vigor after exposure to laboratory stress(Reference Markus and Firk108). It has also been reported that ATS (no data on TRP:LNAA levels) was without effect on mood in 5-HTTLPR s- and l-allele carriers, but lowered hypothalamic–pituitary–adrenal axis activity in individuals being homozygous for the s allele(Reference Cerit, Jans and Van der Does109). In addition, ATS reduced food intake in dieting females regardless of their 5-HTTLPR genotype, while increasing mood and emotional eating solely in l/l subjects (plasma TRP:LNAA ratio increased by 70 %)(Reference Markus, Verschoor and Smeets110). However, it has also been demonstrated that an α-lactalbumin-enhanced diet (21 % increase in TRP:LNAA) failed to modulate mood or vigor in recovered depressed subjects(Reference Merens, Booij and Markus98, Reference Booij, Merens and Markus100), and an increase of 21 % in TRP:LNAA following the administration of two α-lactalbumin-rich drinks had no effect on mood in recovered depressed patients(Reference Booij, Merens and Markus100). Perhaps these TRP:LNAA ratios of about 20 % are too low to improve mood in vulnerable subjects. Overall, ATS seems to have more profound effects on mood in vulnerable populations than in healthy subjects. Potentially, factors such as lower baseline levels of 5-HT and reduced capacity to clear released 5-HT from the synaptic cleft may help to clarify whether ATS has beneficial effects in individuals with mood disturbances.

Cognition

An increase of 21 % in TRP:LNAA following the administration of two α-lactalbumin-rich drinks improved abstract visual memory in both healthy controls and recovered depressed patients(Reference Booij, Merens and Markus100). Another study found that in women with premenstrual complaints, ATS improved memory for abstract figures (29 % increase in TRP:LNAA) and word recognition (6–25 % increase in TRP:LNAA) during the premenstrual stage(Reference Sayegh, Schiff and Wurtman106, Reference Schmitt, Jorissen and Dye107). Furthermore, Markus et al. (Reference Markus, Panhuysen and Jonkman111) reported an enhanced short-term memory scanning in healthy high-stress-prone subjects following laboratory stress and after consumption of a high-carbohydrate low-protein diet (TRP:LNAA ratio increased by 42 %) or after consumption of a diet enriched with α-lactalbumin (Trp:LNAA ratio increased by 43 %)(Reference Markus, Olivier and de Haan112). Together these data suggest that also in vulnerable subjects ATS improves memory-related processes, at rather low increases in plasma TRP:LNAA ratios. As to whether the high Trp-induced sedative effects on cognition as observed in healthy subjects also take place in vulnerable subjects needs to be investigated.

Effects of acute and (sub-)chronic tryptophan supplementation in animal models

As in the case of Trp depletion, the added value of studying Trp supplementation in animals lies in the ability to provide direct 5-HT level read-outs from the whole brain or specific brain areas and assess (sub-)chronic effects of Trp supplementation. Feurté et al. (Reference Feurté, Gerozissis and Regnault113) showed that chronic supplementation of the diet of rats with α-lactalbumin leads to a stable increase of 40 % in plasma TRP:LNAA. Increasing plasma TRP:LNAA levels in rats were found to increase brain 5-HT levels, as dietary sub-chronic Trp supplementation (30 % increase in brain TRP:LNAA) in Sprague–Dawley rats resulted in an increase of 92 % in extracellular 5-HT levels in the dorsal hippocampus. Moreover, the effect of the 5-HT-releasing agent fenfluramine was enhanced as was performance in a differential reinforcement of low rate responding condition (mimicking SSRI treatment)(Reference Stelt, Broersen and Olivier114). Collins et al. (Reference Collins, Kloek and Elliott115) showed that supplementation of an egg white protein hydrolysate replenished brain serotonin stores, even after pharmacological depletion of serotonin from the brain by 3,4-methylenedioxymethamphetamine(Reference Collins, Kloek and Elliott115). In Wistar rats chronic treatment with Trp by oral administration (about 60 % increase in plasma Trp:LNAA) was shown to increase 5-HT levels in the hippocampus by 57 %, in the cortex by 46 % and by 72 % in the rest of the brain, as well as boosting performance in the radial arm maze test and water maze test, indicating improvement in both short- and long-term memory(Reference Haider, Khaliq and Ahmed116, Reference Haider, Khaliq and Haleem117). However, a 7 d Trp treatment in mice suppressed food intake significantly and, more worryingly, increased brain thiobarbituric acid-reactive substances (a measure for oxidative stress)(Reference Coskun, Ozer and Gonul118). Taken together, these data show that it might be worthwhile to investigate whether the positive effects of ATS in human subjects could be maintained when diet is supplemented with Trp over a longer period of time. Although some care should be taken, the increase in oxidative stress following chronic Trp supplementation in mice should not be taken lightly.

Summary of acute tryptophan supplementation

ATS seems to improve mood and cognition in both healthy and vulnerable subjects. Effects of ATS on cognition are more consistent and require lower increases in the plasma TRP:LNAA ratios than needed to improve mood. Yet, for both mood and cognition it has been shown that too high increases in Trp levels result in poorer performances. As serotonin synthesis can theoretically only be increased to a maximum of 200 % due to saturation of TpH2 (see the acute tryptophan supplementation section), it is not likely that the poor performance results from local negative responses to elevated serotonin levels like sensitisation. However, a possible explanation could be sedation, which was reported in one study(Reference Cunliffe, Obeid and Powell-Tuck105), caused by the subsequent synthesis of melatonin from serotonin by serotonin-N-acetyltransferase and hydroxyindole-O-methyltransferase(Reference Hickman, Klein and Dyda119). Taken together, these data suggest that there is an inverted U-shaped curve for plasma Trp levels and mood/cognition. Finally, research in animal models has provided results that seem to justify further investigation of chronic Trp supplementation in human subjects.

Triple monoamine inhibitors

Unbeknownst to the individuals of ancient and medieval times, some of the medicinal herbs they used actually contained monoamine reuptake transporter inhibitors. During the previous decade a number of studies focused on the antidepressant-like effects of extracts from several subspecies of St John's wort (Hypericum perfoliatum), which was traditionally used to treat wounds, eczema and disorders of the central nervous system(Reference Bombardelli and Morazzoni120). Not only did these studies reveal replicable antidepressant effects in mice(Reference do Rego, Benkiki and Chosson121Reference Viana, do Rego and von Poser124), analysis of monoamine uptake by rat synaptosomes showed that uptake of all three monoamines was inhibited by these extracts(Reference do Rego, Benkiki and Chosson121, Reference Viana, do Rego and von Poser124). In addition to St John's wort, the presence of monoamine reuptake inhibitors was shown in the extracts of Siphocampylus verticillatus (a Brazilian medicinal plant)(Reference Rodrigues, da Silva and Mateussi125), in Fructus Akebiae (a traditional Chinese cure for depressive disorders)(Reference Jin, Gao and Zhou126) and Sideritis scardica (used as a tea, flavouring agent and universal remedy around the Mediterranean)(Reference Knörle127).

Perhaps even more surprising is the presence of monoamine transporter inhibitors in regular foods. In 2003, a group of researchers reported on a group of isoflavans and isoflavenes, which are present in licorice, with serotonin transporter (SERT)-inhibiting properties(Reference Ofir, Tamir and Khatib128). After 7 d of oral injections with the extract of the roots of Glycyrrhiza glabra (from which licorice is made), mice showed enhanced learning and memory performance in the passive avoidance paradigm and reduced anxiety in the elevated plus maze(Reference Dhingra, Parle and Kulkarni129), as well as reduced immobility in the forced swim and tail suspension tests for depression(Reference Dhingra and Sharma130). These findings suggest that the extract from G. glabra possesses antidepressant potentials. Recently, Mechan et al. (Reference Mechan, Fowler and Seifert12) demonstrated that a supercritical CO2 oregano extract acting as a moderate noradrenaline, serotonin and dopamine reuptake inhibitor and MAO inhibitor exerted antidepressant-like and anxiolytic effects in mice. In the same study, the researchers used in vivo microdialysis in rats to confirm that extracellular 5-HT levels were indeed higher after a dose of the oregano extract, albeit more slightly compared with the antidepressant fluoxetine. Moreover, electroencephalogram measurements after acute oral supplementation in freely moving rats showed that this extract may exhibit antidepressant and neuroprotective activities(Reference Mohajeri, Goralczyk and Dimpfel131). Taken together, the results of these studies seem to justify further investigation into possible other dietary sources of monoamine reuptake inhibitors, as well as studies testing whether the beneficial behavioural effects of these plant extracts found in mice can be replicated in human subjects. An important fact to note is that the half maximal inhibitory concentration (IC50s) of these plant-derived monoamine reuptake inhibitors are about 1000-fold lower than those of pharmacological compounds, making the chances of detrimental side effects much lower(Reference Mechan, Fowler and Seifert12). In addition, a recent study investigating the attitudes of the general public and general practitioners towards enhancement of mood and cognition in healthy individuals by either pharmaceuticals or natural compounds showed that the public, especially, tends to be more favourable towards natural compounds(Reference Bergström and Lynöe132).

Summary and conclusion

While the serotonergic system is an important target for many pharmacological agents applied in psychiatry, this system is also amenable to influences of food. Indeed, food containing a low TRP:LNAA ratio tends to reduce mood and cognition, and food that increases this ratio may increase mood and cognition in humans. However, as we reviewed, the relationship between Trp intake and behavioural performance is not unequivocal. In part this is because methods that have been used to lower or increase the plasma TRP:LNAA ratio differ considerably across studies. Nonetheless, there may be an inverted U-shaped relationship between central 5-HT levels and optimal mood/cognition; low and too high Trp levels impair mood/cognition, and moderate to high Trp levels improve mood/cognition. Regarding cognition this relationship is found for both healthy and vulnerable subjects (Fig. 1(a)). However, regarding mood, effects of ATD and ATS seem to depend on the functioning of the serotonergic system of vulnerable or subclinical subjects, with a much more profound decrease in mood of vulnerable subjects compared with healthy subjects in the lower brain Trp range (Fig. 1(b)). However, if brain Trp levels are in the optimum range, mood in vulnerable subjects is comparable with mood in healthy subjects. In healthy individuals an increase in plasma TRP:LNAA of 67 % does not modulate mood, while in vulnerable subjects an increase of 20–50 % is sufficient to normalise their brain Trp levels and thus produce positive effects on mood. Such positive effects on mood are only seen in healthy subjects following a 191–255 % increase in plasma TRP:LNAA levels. When plasma Trp levels are elevated beyond that range, mood in both healthy and vulnerable subjects is negatively affected. Given that Western and new world societies are increasingly demanding and food is generally abundantly available in these societies, insight in beneficial TRP:LNAA ratios in food for specific target groups may help the nutrition industry to adapt food to support our mood and cognition.

Fig. 1 Relationship between brain tryptophan (Trp) levels and cognition/mood. In both healthy and vulnerable subjects too low and too high brain Trp levels result in impaired cognitive ability. This indicates that in the case of cognition, brain Trp levels should lie within an optimum range (a). The effects of small increases or decreases in brain Trp levels on the mood of healthy subjects is negligible (b, ). Only large increases in brain Trp levels are able to improve mood significantly in these subjects. Conversely, in vulnerable subjects (b, ) relatively small increases in brain Trp result in an improved mood. Unphysiologically high increases in brain Trp lead to negative effects on mood in both healthy and vulnerable subjects. (A colour version of this figure can be found online at http://www.journals.cambridge.org/nrr)

One group of individuals that is vulnerable to manipulations of the serotonergic system is the one that carries the s allele of the 5-HTTLPR polymorphism. Studies employing 5-HTT knockout mice and rats as a model have revealed that reduced 5-HTT expression (as hypothesised for 5-HTTLPR s-allele carriers) is associated with increased extracellular 5-HT levels, reduced intra-neuronal 5-HT levels and increased 5-HT synthesis. Also, various 5-HT receptors are down-regulated(Reference Kalueff, Olivier and Nonkes32). As to whether Trp levels or its transport over the blood–brain barrier is affected by the 5-HTTLPR genotype is unknown to date. Nonetheless, if 5-HT synthesis is enhanced to compensate lower 5-HT tissue levels, it may not be surprising that 5-HTTLPR s-allele carriers are more sensitive to Trp depletion(Reference Neumeister, Hu and Luckenbaugh74), an effect that has also been observed in 5-HTT knockout rats(Reference Olivier, Jans and Korte-Bouws87). In contrast to ATD, ATS has a positive effect on mood, vigor and cortisol response after exposure to laboratory stress in ss subjects(Reference Markus and Firk108, Reference Cerit, Jans and Van der Does109). 5-HTTLPR s-allele carriers are more sensitive to stress(Reference Owens, Goodyer and Wilkinson133) and are more prone to develop depression after adverse life events(Reference Caspi, Sugden and Moffitt31). Given that ATS has been reported to dampen the negative effects on mood invoked by stress(Reference Markus and Firk108, Reference Cerit, Jans and Van der Does109), it is of interest to test whether (chronic) ATS improves stress coping and decreases risk for depression in s-allele carriers. Finally, to date, no studies on the effects of chronic Trp supplementation in human subjects have been conducted. With the recent discovery of powerful tools for enhancing available Trp through diet, such as hydrolysed protein or egg protein hydrolysate(Reference Mitchell, Slettenaar and Quadt8, Reference Markus, Firk and Gerhardt9), and promising data from ATS studies, chronic Trp supplementation studies in human subjects are warranted. Ultimately, enhancing available Trp in food such as cereals, maize and milk formulas may represent an efficient and cost-effective way of increasing mood and cognition, and thus our general well-being in the current increasingly demanding society. Specifically, insight into beneficial Trp:LNAA ratios in food for specific target groups – as presented here – may help the nutrition industry to increase the functionality of our food. Specifically, contrary to popular belief, most common foods high in Trp do not increase the plasma TRP:LNAA ratio enough to exert any positive effects on mood/cognition, because they also contain large amounts of other LNAA. Hence, functional foods have to be designed containing much higher levels of Trp compared with other LNAA. With about 10 % of the population over 12 years of age taking antidepressants in the USA alone(Reference Pratt, Brody and Gu134) and the numerous side effects associated with their use, consumption of these functional foods to prevent depression in the first place is alluring for both clinicians and the general public.

Acknowledgements

J. R. H. is financially supported by The Netherlands Organisation for Scientific Research (NWO), grant no. 86410003. NWO had no further role in the design of the study, in the collection, analysis and interpretation of data, in the writing of the report, and in the decision to submit the paper for publication.

S. H., A. M., M. H. M. and J. R. H. wrote the manuscript, S. H. organised the references and made the figures, J. R. H. designed the manuscript, and J. R. H. and M. H. M. together wrote the conclusions.

There are no conflicts of interest.

References

1American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association.Google Scholar
2Olivier, B, Chan, JS, Snoeren, EM, et al. (2011) Differences in sexual behaviour in male and female rodents: role of serotonin. Curr Top Behav Neurosci 8, 1536.CrossRefGoogle ScholarPubMed
3Wurtman, RJ, Hefti, F & Melamed, E (1980) Precursor control of neurotransmitter synthesis. Pharmacol Rev 32, 315335.Google ScholarPubMed
4Kerem, Z, Lev-Yadun, S, Gopher, A, et al. (2007) Chickpea domestication in the Neolithic Levant through the nutritional perspective. J Archaeol Sci 34, 12891293.CrossRefGoogle Scholar
5Katz, SH, Hediger, ML & Valleroy, LA (1974) Traditional maize processing techniques in the new world. Science 184, 765773.CrossRefGoogle ScholarPubMed
6Morris, CE & Sands, DC (2006) The breeder's dilemma – yield or nutrition? Nature Biotechnol 24, 10781080.CrossRefGoogle ScholarPubMed
7Heine, W, Radke, M, Wutzke, KD, et al. (1996) α-Lactalbumin-enriched low-protein infant formulas: a comparison to breast milk feeding. Acta Paediatr 85, 10241028.CrossRefGoogle ScholarPubMed
8Mitchell, ES, Slettenaar, M, Quadt, F, et al. (2011) Effect of hydrolysed egg protein on brain tryptophan availability. Br J Nutr 105, 611617.CrossRefGoogle ScholarPubMed
9Markus, CR, Firk, C, Gerhardt, C, et al. (2008) Effect of different tryptophan sources on amino acids availability to the brain and mood in healthy volunteers. Psychopharmacology 201, 107114.CrossRefGoogle Scholar
10Silber, BY & Schmitt, JAJ (2010) Effects of tryptophan loading on human cognition, mood, and sleep. Neurosci Biobehav Rev 34, 387407.CrossRefGoogle ScholarPubMed
11Booij, L, Van der Does, AJ & Riedel, WJ (2003) Monoamine depletion in psychiatric and healthy populations: review. Mol Psychiatry 8, 951973.CrossRefGoogle ScholarPubMed
12Mechan, AO, Fowler, A, Seifert, N, et al. (2011) Monoamine reuptake inhibition and mood-enhancing potential of a specified oregano extract. Br J Nutr 105, 11501163.CrossRefGoogle ScholarPubMed
13Kroeze, Y, Zhou, H & Homberg, JR (2012) The genetics of selective serotonin reuptake inhibitors. Pharmacol Ther 136, 375400.CrossRefGoogle ScholarPubMed
14Neal, KB, Parry, LJ & Bornstein, JC (2009) Strain-specific genetics, anatomy and function of enteric neural serotonergic pathways in inbred mice. J Physiol 587, 567586.CrossRefGoogle ScholarPubMed
15Azmitia, EC & Whitaker-Azmitia, PM (1995) Anatomy, cell biology and plasticity of the serotonergic system. In Psychopharmacology: The Fourth Generation of Progress, pp. 443449 [Bloom, FE and Kupfer, DJ, editors]. New York: Raven Press.Google Scholar
16Gutknecht, L, Kriegebaum, C, Waider, J, et al. (2009) Spatio-temporal expression of tryptophan hydroxylase isoforms in murine and human brain: convergent data from Tph2 knockout mice. Eur Neuropsychopharmacol 19, 266282.CrossRefGoogle ScholarPubMed
17Saura, J, Andrés, N, Andrade, C, et al. (1997) Biphasic and region-specific MAO-B response to aging in normal human brain. Neurobiol Aging 18, 497507.CrossRefGoogle ScholarPubMed
18Torres, GE, Gainetdinov, RR & Caron, MG (2003) Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci 4, 1325.CrossRefGoogle ScholarPubMed
19Van Praag, HM, Korf, J & Puite, J (1970) 5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature 225, 12591260.CrossRefGoogle ScholarPubMed
20Malison, RT, Price, LH, Berman, R, et al. (1998) Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry 44, 10901098.CrossRefGoogle ScholarPubMed
21Cowen, PJ, Power, AC, Ware, CJ, et al. (1994) 5-HT1A receptor sensitivity in major depression. A neuroendocrine study with buspirone. Br J Psychiatry 164, 372379.CrossRefGoogle ScholarPubMed
22Sargent, PA, Kjaer, KH, Bench, CJ, et al. (2000) Brain serotonin 1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 57, 174180.CrossRefGoogle ScholarPubMed
23Nutt, DJ (2002) The neuropharmacology of serotonin and noradrenaline in depression. Int Clin Psychopharmacol 17, S1S12.CrossRefGoogle ScholarPubMed
24Mawson, AR & Jacobs, KW (1978) Corn consumption, tryptophan, and cross-national homicide rates. J Orthomol Psychiatry 7, 227230.Google Scholar
25Voracek, M & Tran, US (2007) Dietary tryptophan intake and suicide rate in industrialized nations. J Affect Disord 98, 259262.CrossRefGoogle ScholarPubMed
26Gordon, JA & Hen, R (2004) The serotonergic system and anxiety. Neuromolecular Med 5, 2740.CrossRefGoogle ScholarPubMed
27McDougle, CJ, Epperson, CN, Price, LH, et al. (1998) Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder. Mol Psychiatry 3, 270273.CrossRefGoogle ScholarPubMed
28van Praag, HM (2004) Can stress cause depression? Prog Neuropsychopharmacol Biol Psychiatry 28, 891907.CrossRefGoogle ScholarPubMed
29Maes, M & Meltzer, H (1995) The serotonin hypothesis of major depression. In Psychopharmacology: The Fourth Generation of Progress, pp. 933944 [Bloom, FE and Kupfer, DJ, editors]. New York: Raven Press.Google Scholar
30Lesch, K-P, Bengel, D, Heils, A, et al. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 15271531.CrossRefGoogle ScholarPubMed
31Caspi, A, Sugden, K, Moffitt, TE, et al. (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386389.CrossRefGoogle ScholarPubMed
32Kalueff, AV, Olivier, JD, Nonkes, LJ, et al. (2010) Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes. Neurosci Biobehav Rev 34, 373386.CrossRefGoogle ScholarPubMed
33Sabol, SZ, Hu, S & Hamer, D (1998) A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 103, 273279.CrossRefGoogle ScholarPubMed
34Deckert, J, Catalano, M, Syagailo, YV, et al. (1999) Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8, 621624.CrossRefGoogle ScholarPubMed
35Ni, X, Sicard, T, Bulgin, N, et al. (2007) Monoamine oxidase A gene is associated with borderline personality disorder. Psychiatr Genet 17, 153157.CrossRefGoogle ScholarPubMed
36Schulze, TG, Müller, DJ, Krauss, H, et al. (2000) Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder. Am J Med Genet 96, 801803.3.0.CO;2-4>CrossRefGoogle ScholarPubMed
37Yu, YW, Tsai, SJ & Hong, CJ (2005) Association study of a monoamine oxidase A gene promoter polymorphism with major depressive disorder and antidepressant response. Neuropsychopharmacology 30, 17191723.CrossRefGoogle ScholarPubMed
38Domschke, K, Braun, M, Ohrmann, P, et al. (2006) Association of the functional − 1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder. Int J Neuropsychopharmacol 9, 349355.CrossRefGoogle ScholarPubMed
39Zhang, X, Gainetdinov, RR, Beaulieu, J-M, et al. (2005) Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45, 1116.CrossRefGoogle ScholarPubMed
40Lin, YM, Chao, SC, Chen, TM, et al. (2007) Association of functional polymorphisms of the human tryptophan hydroxylase 2 gene with risk for bipolar disorder in Han chinese. Arch Gen Psychiatry 64, 10151024.CrossRefGoogle ScholarPubMed
41Cichon, S, Winge, I, Mattheisen, M, et al. (2008) Brain-specific tryptophan hydroxylase 2 (TPH2): a functional Pro206Ser substitution and variation in the 5′-region are associated with bipolar affective disorder. Hum Mol Genet 17, 8797.CrossRefGoogle Scholar
42Ross, DS, Fernstrom, JD & Wurtman, RJ (1973) The role of dietary protein in generating daily rhythms in rat liver tryptophan pyrrolase and tyrosine transaminase. Metabolism 22, 11751184.CrossRefGoogle ScholarPubMed
43Yuwiler, A, Oldendorf, WH, Geller, E, et al. (1977) Effect of albumin binding and amino acid competition on tryptophan uptake into brain. J Neurochem 28, 10151023.CrossRefGoogle ScholarPubMed
44Fernstrom, JD, Larin, F & Wurtman, RJ (1973) Correlation between brain tryptophan and plasma neutral amino acid levels following food consumption in rats. Life Sci 13, 517524.CrossRefGoogle Scholar
45Fernstrom, JD & Wurtman, RJ (1972) Brain serotonin content: physiological regulation by plasma neutral amino acids. Science 178, 414416.CrossRefGoogle ScholarPubMed
46Fernstrom, JD & Faller, DV (1978) Neutral amino acids in the brain: changes in response to food ingestion. J Neurochem 30, 15311538.CrossRefGoogle ScholarPubMed
47Carpenter, LL, Anderson, GM, Pelton, GH, et al. (1998) Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology 19, 2635.CrossRefGoogle ScholarPubMed
48Nishizawa, S, Benkelfat, C, Young, SN, et al. (1997) Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A 94, 53085313.CrossRefGoogle ScholarPubMed
49Williams, WA, Shoaf, SE, Hommer, D, et al. (1999) Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers. J Neurochem 72, 16411647.CrossRefGoogle ScholarPubMed
50Ellenbogen, MA, Young, SN, Dean, P, et al. (1996) Mood response to acute tryptophan depletion in healthy volunteers: sex differences and temporal stability. Neuropsychopharmacology 15, 465474.CrossRefGoogle ScholarPubMed
51Smith, KA, Clifford, EM, Hockney, RA, et al. (1997) Effect of tryptophan depletion on mood in male and female volunteers: a pilot study. Hum Psychopharmacol 12, 111117.3.0.CO;2-M>CrossRefGoogle Scholar
52Smith, SE, Pihl, RO, Young, SN, et al. (1987) A test of possible cognitive and environmental influences on the mood lowering effect of tryptophan depletion in normal males. Psychopharmacology 91, 451457.CrossRefGoogle ScholarPubMed
53Young, SN, Smith, SE, Pihl, RO, et al. (1985) Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology 87, 173177.CrossRefGoogle ScholarPubMed
54Abbott, FV, Etienne, P, Franklin, KBJ, et al. (1992) Acute tryptophan depletion blocks morphine analgesia in the cold-pressor test in humans. Psychopharmacology 108, 6066.CrossRefGoogle ScholarPubMed
55Danjou, P, Hamon, M, Lacomblez, L, et al. (1990) Psychomotor, subjective and neuroendocrine effects of acute tryptophan depletion in the healthy volunteer. Psychiat Psychobiol 5, 3138.CrossRefGoogle Scholar
56Schmitt, JA, Jorissen, BL, Sobczak, S, et al. (2000) Tryptophan depletion impairs memory consolidation but improves focussed attention in healthy young volunteers. J Psychopharmacol 14, 2129.CrossRefGoogle ScholarPubMed
57Scholes, KE, Harrison, BJ, O'Neill, BV, et al. (2006) Acute serotonin and dopamine depletion improves attentional control: findings from the Stroop task. Neuropsychopharmacology 32, 16001610.CrossRefGoogle ScholarPubMed
58Harmer, CJ, Rogers, RD, Tunbridge, E, et al. (2003) Tryptophan depletion decreases the recognition of fear in female volunteers. Psychopharmacology 167, 411417.CrossRefGoogle ScholarPubMed
59Hayward, G, Goodwin, GM, Cowen, PJ, et al. (2005) Low-dose tryptophan depletion in recovered depressed patients induces changes in cognitive processing without depressive symptoms. Biol Psychiatry 57, 517524.CrossRefGoogle ScholarPubMed
60Van Der Veen, FM, Evers, EAT, Deutz, NEP, et al. (2007) Effects of acute tryptophan depletion on mood and facial emotion perception related brain activation and performance in healthy women with and without a family history of depression. Neuropsychopharmacology 32, 216224.CrossRefGoogle ScholarPubMed
61Cools, R, Calder, AJ, Lawrence, AD, et al. (2005) Individual differences in threat sensitivity predict serotonergic modulation of amygdala response to fearful faces. Psychopharmacology 180, 670679.CrossRefGoogle ScholarPubMed
62Riedel, WJ, Klaassen, T, Deutz, NE, et al. (1999) Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology 141, 362369.CrossRefGoogle ScholarPubMed
63McAllister-Williams, R, Massey, A & Rugg, M (2002) Effects of tryptophan depletion on brain potential correlates of episodic memory retrieval. Psychopharmacology 160, 434442.CrossRefGoogle ScholarPubMed
64Benkelfat, C, Ellenbogen, MA, Dean, P, et al. (1994) Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders. Arch Gen Psychiatry 51, 687697.CrossRefGoogle ScholarPubMed
65Klaassen, T, Riedel, WJ, van Someren, A, et al. (1999) Mood effects of 24-hour tryptophan depletion in healthy first-degree relatives of patients with affective disorders. Biol Psychiatry 46, 489497.CrossRefGoogle ScholarPubMed
66Delgado, PL, Charney, DS, Price, LH, et al. (1990) Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 47, 411418.CrossRefGoogle ScholarPubMed
67Delgado, PL, Price, LH, Miller, HL, et al. (1994) Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients. Arch Gen Psychiatry 51, 865874.CrossRefGoogle ScholarPubMed
68Moreno, FA, Gelenberg, AJ, Heninger, GR, et al. (1999) Tryptophan depletion and depressive vulnerability. Biol Psychiatry 46, 498505.CrossRefGoogle ScholarPubMed
69Smith, KA, Fairburn, CG & Cowen, PJ (1999) Symptomatic relapse in bulimia nervosa following acute tryptophan depletion. Arch Gen Psychiatry 56, 171176.CrossRefGoogle ScholarPubMed
70Leyton, M, Young, SN, Blier, P, et al. (1997) The effect of tryptophan depletion on mood in medication-free, former patients with major affective disorder. Neuropsychopharmacology 16, 294297.CrossRefGoogle ScholarPubMed
71Booij, L, Van der Does, AJW, Haffmans, PMJ, et al. (2005) The effects of high-dose and low-dose tryptophan depletion on mood and cognitive functions of remitted depressed patients. J Psychopharmacol 19, 267275.CrossRefGoogle ScholarPubMed
72Merens, W, Booij, L, Haffmans, PJ, et al. (2008) The effects of experimentally lowered serotonin function on emotional information processing and memory in remitted depressed patients. J Psychopharmacol 22, 653662.CrossRefGoogle ScholarPubMed
73Neumeister, A, Konstantinidis, A, Stastny, J, et al. (2002) Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry 59, 613620.CrossRefGoogle ScholarPubMed
74Neumeister, A, Hu, XZ, Luckenbaugh, DA, et al. (2006) Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls. Arch Gen Psychiatry 63, 978986.CrossRefGoogle ScholarPubMed
75Walderhaug, E, Magnusson, A, Neumeister, A, et al. (2007) Interactive effects of sex and 5-HTTLPR on mood and impulsivity during tryptophan depletion in healthy people. Biol Psychiatry 62, 593599.CrossRefGoogle ScholarPubMed
76Walderhaug, E, Herman, AI, Magnusson, A, et al. (2010) The short (S) allele of the serotonin transporter polymorphism and acute tryptophan depletion both increase impulsivity in men. Neurosci Lett 473, 208211.CrossRefGoogle Scholar
77Firk, C & Markus, CR (2009) Differential effects of 5-HTTLPR genotypes on mood, memory, and attention bias following acute tryptophan depletion and stress exposure. Psychopharmacology 203, 805818.CrossRefGoogle ScholarPubMed
78Sambeth, A, Blokland, A, Harmer, CJ, et al. (2007) Sex differences in the effect of acute tryptophan depletion on declarative episodic memory: a pooled analysis of nine studies. Neurosci Biobehav Rev 31, 516529.CrossRefGoogle ScholarPubMed
79Roiser, JP, Blackwell, AD, Cools, R, et al. (2006) Serotonin transporter polymorphism mediates vulnerability to loss of incentive motivation following acute tryptophan depletion. Neuropsychopharmacology 31, 22642272.CrossRefGoogle ScholarPubMed
80Porter, RJ, Phipps, AJ, Gallagher, P, et al. (2005) Effects of acute tryptophan depletion on mood and cognitive functioning in older recovered depressed subjects. Am J Geriatr Psychiatry 13, 607615.CrossRefGoogle ScholarPubMed
81Roiser, JP, Muller, U, Clark, L, et al. (2007) The effects of acute tryptophan depletion and serotonin transporter polymorphism on emotional processing in memory and attention. Int J Neuropsychopharmacol 10, 449461.CrossRefGoogle ScholarPubMed
82Franklin, M, Bermudez, I, Murck, H, et al. (2012) Sub-chronic dietary tryptophan depletion – an animal model of depression with improved face and good construct validity. J Psychiatr Res 46, 239247.CrossRefGoogle ScholarPubMed
83Izquierdo, A, Carlos, K, Ostrander, S, et al. (2012) Impaired reward learning and intact motivation after serotonin depletion in rats. Behav Brain Res 233, 494499.CrossRefGoogle ScholarPubMed
84Koot, S, Zoratto, F, Cassano, T, et al. (2012) Compromised decision-making and increased gambling proneness following dietary serotonin depletion in rats. Neuropharmacology 62, 16401650.CrossRefGoogle ScholarPubMed
85Long, AB, Kuhn, CM & Platt, ML (2009) Serotonin shapes risky decision making in monkeys. Soc Cogn Affect Neurosci 4, 346356.CrossRefGoogle ScholarPubMed
86Jenkins, TA, Elliott, JJ, Ardis, TC, et al. (2010) Tryptophan depletion impairs object-recognition memory in the rat: reversal by risperidone. Behav Brain Res 208, 479483.CrossRefGoogle ScholarPubMed
87Olivier, JDA, Jans, LAW, Korte-Bouws, GAH, et al. (2008) Acute tryptophan depletion dose dependently impairs object memory in serotonin transporter knockout rats. Psychopharmacology 200, 243254.CrossRefGoogle ScholarPubMed
88Nakamaru-Ogiso, E, Miyamoto, H, Hamada, K, et al. (2012) Novel biochemical manipulation of brain serotonin reveals a role of serotonin in the circadian rhythm of sleep–wake cycles. Eur J Neurosci 35, 17621770.CrossRefGoogle ScholarPubMed
89Jans, L, Korte-Bouws, G, Korte, S, et al. (2010) The effects of acute tryptophan depletion on affective behaviour and cognition in Brown Norway and Sprague Dawley rats. J Psychopharmacol 24, 605614.CrossRefGoogle ScholarPubMed
90Fernstrom, JD (1990) Aromatic amino acids and monoamine synthesis in the central nervous system: influence of the diet. J Nutr Biochem 1, 508517.CrossRefGoogle ScholarPubMed
91Fernstrom, JD & Wurtman, RJ (1971) Brain serotonin content: increase following ingestion of carbohydrate diet. Science 174, 10231025.CrossRefGoogle ScholarPubMed
92Yokogoshi, H & Wurtman, RJ (1986) Meal composition and plasma amino acid ratios: effect of various proteins or carbohydrates, and of various protein concentrations. Metabolism 35, 837842.CrossRefGoogle ScholarPubMed
93Markus, CR, Olivier, B, Panhuysen, GE, et al. (2000) The bovine protein α-lactalbumin increases the plasma ratio of tryptophan to the other large neutral amino acids, and in vulnerable subjects raises brain serotonin activity, reduces cortisol concentration, and improves mood under stress. Am J Clin Nutr 71, 15361544.CrossRefGoogle Scholar
94Orosco, M, Rouch, C, Beslot, F, et al. (2004) α-Lactalbumin-enriched diets enhance serotonin release and induce anxiolytic and rewarding effects in the rat. Behav Brain Res 148, 110.CrossRefGoogle ScholarPubMed
95Attenburrow, MJ, Williams, C, Odontiadis, J, et al. (2003) Acute administration of nutritionally sourced tryptophan increases fear recognition. Psychopharmacology 169, 104107.CrossRefGoogle ScholarPubMed
96Murphy, SE, Longhitano, C, Ayres, RE, et al. (2006) Tryptophan supplementation induces a positive bias in the processing of emotional material in healthy female volunteers. Psychopharmacology 187, 121130.CrossRefGoogle ScholarPubMed
97Markus, CR, Panhuysen, G, Tuiten, A, et al. (1998) Does carbohydrate-rich, protein-poor food prevent a deterioration of mood and cognitive performance of stress-prone subjects when subjected to a stressful task? Appetite 31, 4965.CrossRefGoogle ScholarPubMed
98Merens, W, Booij, L, Markus, R, et al. (2005) The effects of a diet enriched with α-lactalbumin on mood and cortisol response in unmedicated recovered depressed subjects and controls. Br J Nutr 94, 415422.CrossRefGoogle ScholarPubMed
99Scrutton, H, Carbonnier, A, Cowen, PJ, et al. (2007) Effects of α-lactalbumin on emotional processing in healthy women. J Psychopharmacol 21, 519524.CrossRefGoogle ScholarPubMed
100Booij, L, Merens, W, Markus, CR, et al. (2006) Diet rich in α-lactalbumin improves memory in unmedicated recovered depressed patients and matched controls. J Psychopharmacol 20, 526535.CrossRefGoogle Scholar
101Sobczak, S, Honig, A, Van Duinen, MA, et al. (2002) Mood, prolactin and cortisol responses following intravenous l-tryptophan challenge: evidence for serotonergic vulnerability in first-degree relatives of bipolar patients. Int J Neuropsychopharmacol 5, 249254.CrossRefGoogle ScholarPubMed
102Sobczak, S, Honig, A, Schmitt, JA, et al. (2003) Pronounced cognitive deficits following an intravenous l-tryptophan challenge in first-degree relatives of bipolar patients compared to healthy controls. Neuropsychopharmacology 28, 711719.CrossRefGoogle ScholarPubMed
103Luciana, M, Burgund, ED, Berman, M, et al. (2001) Effects of tryptophan loading on verbal, spatial and affective working memory functions in healthy adults. J Psychopharmacol 15, 219230.CrossRefGoogle ScholarPubMed
104Morgan, RM, Parry, AMM, Arida, RM, et al. (2007) Effects of elevated plasma tryptophan on brain activation associated with the Stroop task. Psychopharmacology 190, 383389.CrossRefGoogle ScholarPubMed
105Cunliffe, A, Obeid, OA & Powell-Tuck, J (1998) A placebo controlled investigation of the effects of tryptophan or placebo on subjective and objective measures of fatigue. Eur J Clin Nutr 52, 425430.CrossRefGoogle ScholarPubMed
106Sayegh, R, Schiff, I, Wurtman, J, et al. (1995) The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome. Obstet Gynecol 86, 520528.CrossRefGoogle ScholarPubMed
107Schmitt, JAJ, Jorissen, BL, Dye, L, et al. (2005) Memory function in women with premenstrual complaints and the effect of serotonergic stimulation by acute administration of an α-lactalbumin protein. J Psychopharmacol 19, 375384.CrossRefGoogle ScholarPubMed
108Markus, CR & Firk, C (2009) Differential effects of tri-allelic 5-HTTLPR polymorphisms in healthy subjects on mood and stress performance after tryptophan challenge. Neuropsychopharmacology 34, 26672674.CrossRefGoogle ScholarPubMed
109Cerit, H, Jans, LAW & Van der Does, W (2012) The effect of tryptophan on the cortisol response to social stress is modulated by the 5-HTTLPR genotype. Psychoneuroendocrinology 38, 201208.CrossRefGoogle ScholarPubMed
110Markus, CR, Verschoor, E & Smeets, T (2012) Differential effect of the 5-HTT gene-linked polymorphic region on emotional eating during stress exposure following tryptophan challenge. J Nutr Biochem 23, 410416.CrossRefGoogle ScholarPubMed
111Markus, CR, Panhuysen, G, Jonkman, LM, et al. (1999) Carbohydrate intake improves cognitive performance of stress-prone individuals under controllable laboratory stress. Br J Nutr 82, 457467.CrossRefGoogle ScholarPubMed
112Markus, CR, Olivier, B & de Haan, EH (2002) Whey protein rich in α-lactalbumin increases the ratio of plasma tryptophan to the sum of the other large neutral amino acids and improves cognitive performance in stress-vulnerable subjects. Am J Clin Nutr 75, 10511056.CrossRefGoogle Scholar
113Feurté, S, Gerozissis, K, Regnault, A, et al. (2001) Plasma Trp/LNAA ratio increases during chronic ingestion of an α-lactalbumin diet in rats. Nutr Neurosci 4, 413418.CrossRefGoogle ScholarPubMed
114Stelt, H, Broersen, L, Olivier, B, et al. (2004) Effects of dietary tryptophan variations on extracellular serotonin in the dorsal hippocampus of rats. Psychopharmacology 172, 137144.CrossRefGoogle ScholarPubMed
115Collins, CM, Kloek, J & Elliott, JM (2013) Parallel changes in serotonin levels in brain and blood following acute administration of MDMA. J Psychopharmacol 27, 109112.CrossRefGoogle ScholarPubMed
116Haider, S, Khaliq, S, Ahmed, SP, et al. (2006) Long-term tryptophan administration enhances cognitive performance and increases 5HT metabolism in the hippocampus of female rats. Amino Acids 31, 421425.CrossRefGoogle ScholarPubMed
117Haider, S, Khaliq, S & Haleem, DJ (2007) Enhanced serotonergic neurotransmission in the hippocampus following tryptophan administration improves learning acquisition and memory consolidation in rats. Pharmacol Rep 59, 5357.Google ScholarPubMed
118Coskun, S, Ozer, C, Gonul, B, et al. (2006) The effect of repeated tryptophan administration on body weight, food intake, brain lipid peroxidation and serotonin immunoreactivity in mice. Mol Cell Biochem 286, 133138.CrossRefGoogle ScholarPubMed
119Hickman, AB, Klein, DC & Dyda, F (1999) Melatonin biosynthesis. Mol Cell 3, 2332.CrossRefGoogle ScholarPubMed
120Bombardelli, E & Morazzoni, P (1995) Hypericum perforatum. Fitoterapia 66, 4368.Google Scholar
121do Rego, J-C, Benkiki, N, Chosson, E, et al. (2007) Antidepressant-like effect of hyperfoliatin, a polyisoprenylated phloroglucinol derivative from Hypericum perfoliatum (Clusiaceae) is associated with an inhibition of neuronal monoamines uptake. Eur J Pharmacol 569, 197203.CrossRefGoogle ScholarPubMed
122Sánchez-Mateo, CC, Bonkanka, CX & Rabanal, RM (2009) Hypericum grandifolium Choisy: a species native to Macaronesian region with antidepressant effect. J Ethnopharmacol 121, 297303.CrossRefGoogle Scholar
123Skalisz, LL, Beijamini, V & Andreatini, R (2004) Effect of Hypericum perforatum on marble-burying by mice. Phytother Res 18, 399402.CrossRefGoogle ScholarPubMed
124Viana, A, do Rego, J-C, von Poser, G, et al. (2005) The antidepressant-like effect of Hypericum caprifoliatum Cham & Schlecht (Guttiferae) on forced swimming test results from an inhibition of neuronal monoamine uptake. Neuropharmacology 49, 10421052.CrossRefGoogle ScholarPubMed
125Rodrigues, AL, da Silva, GL, Mateussi, AS, et al. (2002) Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus. Life Sci 70, 13471358.CrossRefGoogle ScholarPubMed
126Jin, Z-L, Gao, N, Zhou, D, et al. (2012) The extracts of Fructus Akebiae, a preparation containing 90 % of the active ingredient hederagenin: serotonin, norepinephrine and dopamine reuptake inhibitor. Pharmacol Biochem Behav 100, 431439.CrossRefGoogle ScholarPubMed
127Knörle, R (2012) Extracts of Sideritis scardica as triple monoamine reuptake inhibitors. J Neural Transm 119, 14771482.CrossRefGoogle ScholarPubMed
128Ofir, R, Tamir, S, Khatib, S, et al. (2003) Inhibition of serotonin re-uptake by licorice constituents. J Mol Neurosci 20, 135140.CrossRefGoogle ScholarPubMed
129Dhingra, D, Parle, M & Kulkarni, SK (2004) Memory enhancing activity of Glycyrrhiza glabra in mice. J Ethnopharmacology 91, 361365.CrossRefGoogle ScholarPubMed
130Dhingra, D & Sharma, A (2006) Antidepressant-like activity of Glycyrrhiza glabra L. in mouse models of immobility tests. Prog Neuropsychopharmacol Biol Psychiatry 30, 449454.CrossRefGoogle ScholarPubMed
131Mohajeri, MH, Goralczyk, R & Dimpfel, W (2012) Modulation of neurotransmission by a specified oregano extract alters brain electrical potentials indicative of antidepressant-like and neuroprotective activities. Neurosci Med 3, 3746.CrossRefGoogle Scholar
132Bergström, LS & Lynöe, N (2008) Enhancing concentration, mood and memory in healthy individuals: an empirical study of attitudes among general practitioners and the general population. Scand J Public Health 36, 532537.CrossRefGoogle ScholarPubMed
133Owens, M, Goodyer, IM, Wilkinson, P, et al. (2012) 5-HTTLPR and early childhood adversities moderate cognitive and emotional processing in adolescence. PLOS ONE 7, e48482.CrossRefGoogle ScholarPubMed
134Pratt, LA, Brody, DJ & Gu, Q (2011) Antidepressant use in persons aged 12 and over: United States, 2005–2008. In NCHS Data Brief, no. 76. Hyattsville, MD: National Center for Health Statistics.Google Scholar
Figure 0

Fig. 1 Relationship between brain tryptophan (Trp) levels and cognition/mood. In both healthy and vulnerable subjects too low and too high brain Trp levels result in impaired cognitive ability. This indicates that in the case of cognition, brain Trp levels should lie within an optimum range (a). The effects of small increases or decreases in brain Trp levels on the mood of healthy subjects is negligible (b, ). Only large increases in brain Trp levels are able to improve mood significantly in these subjects. Conversely, in vulnerable subjects (b, ) relatively small increases in brain Trp result in an improved mood. Unphysiologically high increases in brain Trp lead to negative effects on mood in both healthy and vulnerable subjects. (A colour version of this figure can be found online at http://www.journals.cambridge.org/nrr)